OLED

Universal Display Corp. (OLED) - Q1 2026 Filing Summary

Business Context and Reporting Period

This summary covers the unaudited Form 10-Q for Universal Display Corporation for the quarterly period ended March 31, 2026. The Company is a leader in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials. Its primary revenue streams include the sale of OLED materials, royalty and license fees from technology licensing, and contract research services provided by its subsidiary, Adesis.

Key Financial Metrics

Note: Total Investments includes short-term investments ($357.1M) and long-term investments ($395.0M) as of March 31, 2026.

Material Changes vs. Prior Period

• Revenue Decline: Total revenue decreased 14.5% year-over-year. Material sales fell 3% due to lower unit volumes and customer mix changes. Royalty and license fees dropped 26% primarily due to customer mix and lower unit volumes. Contract research services revenue declined 35% due to decreased demand at the Adesis subsidiary.
• Profitability: Net income decreased 44% to $35.9 million. Operating income fell 39% to $42.8 million. Gross margin percentage decreased to 74.6% from 77.1%.
• Operating Expenses: Total operating expenses increased 8.3% to $63.3 million. Increases were driven by higher amortization of acquired technology ($5.6M vs $4.5M) due to the January 2026 Merck KGaA patent acquisition, increased SG&A expenses, and higher patent costs.
• Non-Operating Items: "Other (loss) income, net" swung from a gain of $0.4M in Q1 2025 to a loss of $6.2M in Q1 2026. This was driven by a $3.0M foreign exchange loss on a Korean Won receivable, a $2.7M loss on marketable equity securities, and a $0.4M impairment on minority equity investments.
• Cash Flow: Operating cash flow improved significantly to $108.9M (vs $30.6M prior year), largely due to a $39.0M tax refund receipt from the U.S. Treasury and a $26.3M decrease in accounts receivable.

Guidance, Outlook, and Risks

• Share Repurchases: The Company completed a $100.0 million share repurchase program in Q1 2026. On April 28, 2026, the Board authorized a new program to repurchase up to an additional $400.0 million of common stock.
• Dividends: A quarterly dividend of $0.50 per share was declared for Q1 2026. A second quarter dividend of $0.50 per share was declared on April 28, 2026, payable June 30, 2026.
• Strategic Acquisitions: The Company closed the acquisition of over 300 OLED-related patents from Merck KGaA in January 2026 for $50.0 million, increasing amortization expenses.
• Legal & Tax Contingencies: The Company is involved in ongoing litigation regarding Korean withholding taxes. A $50.8 million receivable is recorded for a potential refund, though the outcome remains uncertain pending a court decision scheduled for July 2026. The Company is also undergoing federal and state tax audits.
• Outlook: Management expects customer mix in subsequent periods of 2026 to have a more favorable impact on royalty and license fees compared to Q1. The Company believes it has sufficient liquidity to meet obligations for at least the next twelve months.

Investor Verification Checklist

• Customer Concentration: Verify the impact of the top two customers (Customer A at 49% and Customer B at 25% of Q1 revenue) on future revenue stability.
• Korean Tax Litigation: Monitor the July 2026 court date regarding the $50.8 million Korean withholding tax receivable and the potential impact on future tax liabilities.
• Amortization Impact: Assess the long-term effect of the new $50M Merck KGaA patent acquisition on future operating margins due to increased amortization.
• Share Buyback Execution: Track the execution of the new $400M share repurchase authorization and its impact on diluted share count.
• Adesis Performance: Evaluate the trend in contract research services revenue, which declined 35% YoY, to determine if this is a temporary demand fluctuation or a structural shift.